Is CVS Health Stock Undervalued?
CVS Health (NYSE:CVS) share price declined by over 23% over…
Sell
47
WALD Quote, Financials, Valuation and Earnings
Last price:
$3.45
Seasonality move
:
-7.86%
Day range:
$3.29 - $3.47
52-week range:
$2.41 - $8.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.42x
P/B ratio:
0.67x
Volume:
31.2K
Avg. volume:
100.8K
1-year change:
-50.92%
Market cap:
$414M
Revenue:
$218.1M
EPS (TTM):
-$0.74
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
$70.4M | -$0.07 | -- | -- | $5.76 |
|
EWCZ
European Wax Center
|
$52.2M | $0.06 | -8.05% | 13.44% | $8.06 |
|
GROV
Grove Collaborative Holdings
|
$48.8M | -$0.15 | -18.49% | -44.44% | $2.50 |
|
HIMS
Hims & Hers Health
|
$469.7M | $0.21 | 90.44% | 2050% | $26.20 |
|
KVUE
Kenvue
|
$3.8B | $0.26 | 1.95% | 99.12% | $24.44 |
|
SKIN
The Beauty Health
|
$78M | -$0.09 | -19.69% | -12.5% | $1.72 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
$3.37 | $5.76 | $414M | -- | $0.00 | 0% | 1.42x |
|
EWCZ
European Wax Center
|
$6.75 | $8.06 | $302.1M | 29.40x | $0.00 | 0% | 1.45x |
|
GROV
Grove Collaborative Holdings
|
$1.43 | $2.50 | $56.3M | -- | $0.00 | 0% | 0.24x |
|
HIMS
Hims & Hers Health
|
$37.28 | $26.20 | $8.1B | 84.73x | $0.00 | 0% | 6.84x |
|
KVUE
Kenvue
|
$21.29 | $24.44 | $40.8B | 38.71x | $0.21 | 3.81% | 2.65x |
|
SKIN
The Beauty Health
|
$1.67 | $1.72 | $207.3M | -- | $0.00 | 0% | 0.65x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WALD
Waldencast PLC
|
21.71% | 0.110 | 29.49% | 0.68x |
|
EWCZ
European Wax Center
|
84.51% | -1.259 | 106.6% | 2.00x |
|
GROV
Grove Collaborative Holdings
|
54.96% | 2.374 | 41.26% | 1.28x |
|
HIMS
Hims & Hers Health
|
-- | 8.428 | -- | 1.69x |
|
KVUE
Kenvue
|
44.98% | 1.424 | 19.63% | 0.66x |
|
SKIN
The Beauty Health
|
90.23% | 0.331 | 308.53% | 5.35x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
-- | -- | -7.46% | -9.22% | -- | -- |
|
EWCZ
European Wax Center
|
$40.4M | $9.5M | 2.28% | 9.59% | 16.58% | $14.8M |
|
GROV
Grove Collaborative Holdings
|
$25.6M | -$6.7M | -29.08% | -125.41% | 3.35% | $264K |
|
HIMS
Hims & Hers Health
|
$317.9M | $22.4M | 27.83% | 27.83% | 5.57% | $79.4M |
|
KVUE
Kenvue
|
$2.3B | $703M | 5.56% | 9.94% | 17.26% | $190M |
|
SKIN
The Beauty Health
|
$40.6M | -$21.5M | -3.93% | -41.24% | -17.61% | $8.2M |
Waldencast PLC vs. Competitors
-
Which has Higher Returns WALD or EWCZ?
European Wax Center has a net margin of -- compared to Waldencast PLC's net margin of 2.67%. Waldencast PLC's return on equity of -9.22% beat European Wax Center's return on equity of 9.59%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $932M EWCZEuropean Wax Center72.93% $0.03 $474.8M -
What do Analysts Say About WALD or EWCZ?
Waldencast PLC has a consensus price target of $5.76, signalling upside risk potential of 70.92%. On the other hand European Wax Center has an analysts' consensus of $8.06 which suggests that it could grow by 19.44%. Given that Waldencast PLC has higher upside potential than European Wax Center, analysts believe Waldencast PLC is more attractive than European Wax Center.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 EWCZEuropean Wax Center3 5 1 -
Is WALD or EWCZ More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or EWCZ?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. European Wax Center pays out 31.9% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WALD or EWCZ?
Waldencast PLC quarterly revenues are --, which are smaller than European Wax Center quarterly revenues of $55.4M. Waldencast PLC's net income of -- is lower than European Wax Center's net income of $1.5M. Notably, Waldencast PLC's price-to-earnings ratio is -- while European Wax Center's PE ratio is 29.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 1.42x versus 1.45x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC1.42x -- -- -- EWCZEuropean Wax Center1.45x 29.40x $55.4M $1.5M
-
Which has Higher Returns WALD or GROV?
Grove Collaborative Holdings has a net margin of -- compared to Waldencast PLC's net margin of -2.77%. Waldencast PLC's return on equity of -9.22% beat Grove Collaborative Holdings's return on equity of -125.41%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $932M GROVGrove Collaborative Holdings53.03% -$0.04 $58.5M -
What do Analysts Say About WALD or GROV?
Waldencast PLC has a consensus price target of $5.76, signalling upside risk potential of 70.92%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.50 which suggests that it could grow by 74.83%. Given that Grove Collaborative Holdings has higher upside potential than Waldencast PLC, analysts believe Grove Collaborative Holdings is more attractive than Waldencast PLC.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 GROVGrove Collaborative Holdings2 0 0 -
Is WALD or GROV More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or GROV?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or GROV?
Waldencast PLC quarterly revenues are --, which are smaller than Grove Collaborative Holdings quarterly revenues of $48.3M. Waldencast PLC's net income of -- is lower than Grove Collaborative Holdings's net income of -$1.3M. Notably, Waldencast PLC's price-to-earnings ratio is -- while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 1.42x versus 0.24x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC1.42x -- -- -- GROVGrove Collaborative Holdings0.24x -- $48.3M -$1.3M
-
Which has Higher Returns WALD or HIMS?
Hims & Hers Health has a net margin of -- compared to Waldencast PLC's net margin of 18.82%. Waldencast PLC's return on equity of -9.22% beat Hims & Hers Health's return on equity of 27.83%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $932M HIMSHims & Hers Health79.16% $0.32 $440.1M -
What do Analysts Say About WALD or HIMS?
Waldencast PLC has a consensus price target of $5.76, signalling upside risk potential of 70.92%. On the other hand Hims & Hers Health has an analysts' consensus of $26.20 which suggests that it could fall by -29.73%. Given that Waldencast PLC has higher upside potential than Hims & Hers Health, analysts believe Waldencast PLC is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 HIMSHims & Hers Health3 6 1 -
Is WALD or HIMS More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.352, suggesting its more volatile than the S&P 500 by 35.191%.
-
Which is a Better Dividend Stock WALD or HIMS?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or HIMS?
Waldencast PLC quarterly revenues are --, which are smaller than Hims & Hers Health quarterly revenues of $401.6M. Waldencast PLC's net income of -- is lower than Hims & Hers Health's net income of $75.6M. Notably, Waldencast PLC's price-to-earnings ratio is -- while Hims & Hers Health's PE ratio is 84.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 1.42x versus 6.84x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC1.42x -- -- -- HIMSHims & Hers Health6.84x 84.73x $401.6M $75.6M
-
Which has Higher Returns WALD or KVUE?
Kenvue has a net margin of -- compared to Waldencast PLC's net margin of 9.82%. Waldencast PLC's return on equity of -9.22% beat Kenvue's return on equity of 9.94%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $932M KVUEKenvue58.53% $0.20 $19.3B -
What do Analysts Say About WALD or KVUE?
Waldencast PLC has a consensus price target of $5.76, signalling upside risk potential of 70.92%. On the other hand Kenvue has an analysts' consensus of $24.44 which suggests that it could grow by 14.78%. Given that Waldencast PLC has higher upside potential than Kenvue, analysts believe Waldencast PLC is more attractive than Kenvue.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 KVUEKenvue3 11 0 -
Is WALD or KVUE More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or KVUE?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.81% to investors and pays a quarterly dividend of $0.21 per share. Waldencast PLC pays -- of its earnings as a dividend. Kenvue pays out 874.64% of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or KVUE?
Waldencast PLC quarterly revenues are --, which are smaller than Kenvue quarterly revenues of $3.9B. Waldencast PLC's net income of -- is lower than Kenvue's net income of $383M. Notably, Waldencast PLC's price-to-earnings ratio is -- while Kenvue's PE ratio is 38.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 1.42x versus 2.65x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC1.42x -- -- -- KVUEKenvue2.65x 38.71x $3.9B $383M
-
Which has Higher Returns WALD or SKIN?
The Beauty Health has a net margin of -- compared to Waldencast PLC's net margin of -23.21%. Waldencast PLC's return on equity of -9.22% beat The Beauty Health's return on equity of -41.24%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $932M SKINThe Beauty Health51.58% -$0.15 $611.1M -
What do Analysts Say About WALD or SKIN?
Waldencast PLC has a consensus price target of $5.76, signalling upside risk potential of 70.92%. On the other hand The Beauty Health has an analysts' consensus of $1.72 which suggests that it could grow by 2.8%. Given that Waldencast PLC has higher upside potential than The Beauty Health, analysts believe Waldencast PLC is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 SKINThe Beauty Health0 7 0 -
Is WALD or SKIN More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or SKIN?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or SKIN?
Waldencast PLC quarterly revenues are --, which are smaller than The Beauty Health quarterly revenues of $78.8M. Waldencast PLC's net income of -- is lower than The Beauty Health's net income of -$18.3M. Notably, Waldencast PLC's price-to-earnings ratio is -- while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 1.42x versus 0.65x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC1.42x -- -- -- SKINThe Beauty Health0.65x -- $78.8M -$18.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Can RTX Stock Go?
Needless to say, the geopolitical landscape has heated up significantly…
What Is Recency Bias in Investing?
Recency bias is a cognitive error that happens when people…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Sell
38
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 101x
Alerts
Buy
54
DECK alert for Feb 1
Deckers Outdoor [DECK] is down 20.35% over the past day.
Sell
49
EXOD alert for Feb 1
Exodus Movement [EXOD] is down 18.88% over the past day.
Buy
69
HZO alert for Feb 1
MarineMax [HZO] is down 0.13% over the past day.
